Assignee
ADAMED PHARMA S A
PL·6 granted patents·2 pending applications·7 citations·filing 2018–2025
Top patents by PatentIndex Score
8 records- 0187US11981668B2Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonistsADAMED PHARMA S A·Filed 2021·Granted May 14, 2024·2 cites·20 claims
- 0283US11034688B2Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonistsADAMED PHARMA S A·Filed 2019·Granted Jun 15, 2021·3 cites·20 claims
- 0379US11684608B2Treatment of a bacterial vaginal infectionADAMED PHARMA S A·Filed 2018·Granted Jun 27, 2023·2 cites·13 claims
- 0478US12319682B2Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonistsADAMED PHARMA S A·Filed 2024·Granted Jun 3, 2025·0 cites·20 claims
- 0574US12343332B2Treatment of a bacterial vaginal infectionADAMED PHARMA S A·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 0668US2025295635A1Treatment of a bacterial vaginal infectionADAMED PHARMA S A·Filed 2025·Application pending·0 cites
- 0752US2023058142A1Liquid pharmaceutical composition comprising cytisineADAMED PHARMA S A·Filed 2020·Application pending·0 cites
- 0827US12415811B21,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-C]pyrrole]-2,3'-dione compounds as therapeutic agents activating TP53ADAMED PHARMA S A·Filed 2019·Granted Sep 16, 2025·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →